Dr. Michael Piacentini, M.D

NPI: 1477547941
Total Payments
$383.66
2024 Payments
$55.24
Companies
10
Transactions
17
Medicare Patients
5,149
Medicare Billing
$388,147

Payment Breakdown by Category

Food & Beverage$383.66 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $383.66 17 100.0%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $118.47 5 $0 (2023)
Alcon Vision LLC $48.57 2 $0 (2022)
SUN PHARMACEUTICAL INDUSTRIES INC. $44.65 2 $0 (2024)
Shire North American Group Inc $43.53 2 $0 (2019)
ABBVIE INC. $24.77 1 $0 (2023)
Bausch & Lomb Americas Inc. $24.58 1 $0 (2024)
Aerie Pharmaceuticals, Inc. $23.88 1 $0 (2018)
Oyster Point Pharma, Inc. $20.47 1 $0 (2023)
EYEVANCE PHARMACEUTICALS LLC $19.36 1 $0 (2022)
NovaBay Pharmaceuticals, Inc. $15.38 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $55.24 2 SUN PHARMACEUTICAL INDUSTRIES INC. ($30.66)
2023 $72.63 3 Novartis Pharmaceuticals Corporation ($27.39)
2022 $38.77 2 Alcon Vision LLC ($19.41)
2020 $29.16 1 Alcon Vision LLC ($29.16)
2019 $71.06 3 Novartis Pharmaceuticals Corporation ($46.70)
2018 $44.96 2 Aerie Pharmaceuticals, Inc. ($23.88)
2017 $71.84 4 Novartis Pharmaceuticals Corporation ($23.30)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/13/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Cequa (Drug) Food and Beverage In-kind items and services $30.66 General
Category: Ophthalmology
04/22/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $24.58 General
Category: Ophthalmology
08/16/2023 ABBVIE INC. VUITY (Drug), LUMIGAN, ALPHAGAN P Food and Beverage In-kind items and services $24.77 General
Category: EYE CARE
08/10/2023 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Food and Beverage In-kind items and services $27.39 General
Category: Ophthalmology
07/06/2023 Oyster Point Pharma, Inc. TYRVAYA (Drug) Food and Beverage In-kind items and services $20.47 General
Category: DRY EYE
09/01/2022 EYEVANCE PHARMACEUTICALS LLC Flarex (Drug) Food and Beverage In-kind items and services $19.36 General
Category: OPHTHALMIC
06/28/2022 Alcon Vision LLC rocklatan (Drug), rhopressa Food and Beverage In-kind items and services $19.41 General
Category: Glaucoma
02/04/2020 Alcon Vision LLC ILUX (Device) Food and Beverage In-kind items and services $29.16 General
Category: Ophthalmology
11/19/2019 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Food and Beverage In-kind items and services $24.36 General
Category: OPHTHALMOLOGY
07/18/2019 Novartis Pharmaceuticals Corporation TRAVATAN Z (Drug) Food and Beverage In-kind items and services $22.34 General
Category: OPHTHALMOLOGY
05/07/2019 Shire North American Group Inc XIIDRA (Drug) Food and Beverage In-kind items and services $24.36 General
Category: OPTHALMICS
11/29/2018 Novartis Pharmaceuticals Corporation TRAVATAN Z (Drug) Food and Beverage In-kind items and services $21.08 General
Category: OPHTHALMOLOGY
08/30/2018 Aerie Pharmaceuticals, Inc. Rhopressa (Drug) Food and Beverage In-kind items and services $23.88 General
Category: Ophthalmology
08/28/2017 NovaBay Pharmaceuticals, Inc. Avenova (Device) Food and Beverage Cash or cash equivalent $15.38 General
Category: Ophthalmology
07/07/2017 Sun Pharmaceutical Industries Inc. Bromsite (Drug) Food and Beverage In-kind items and services $13.99 General
Category: Ophthalmology
05/09/2017 Novartis Pharmaceuticals Corporation PAZEO (Drug) Food and Beverage In-kind items and services $23.30 General
Category: OPHTHALMOLOGY
03/21/2017 Shire North American Group Inc XIIDRA (Drug) Food and Beverage In-kind items and services $19.17 General
Category: OPTHALMICS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 1,465 1,573 $201,730 $110,653
2022 9 1,411 1,504 $197,395 $105,531
2021 9 1,271 1,330 $173,305 $97,185
2020 9 1,002 1,041 $136,490 $74,778
Total Patients
5,149
Total Services
5,448
Medicare Billing
$388,147
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2023 743 779 $119,685 $73,425 61.3%
92012 Established patient problem focused exam of visual system Office 2023 192 234 $26,300 $15,252 58.0%
92083 Exam of visual field with extended testing Office 2023 176 193 $19,600 $8,028 41.0%
92004 New patient complete exam of visual system Office 2023 50 50 $9,820 $5,476 55.8%
92133 Imaging of optic nerve Office 2023 150 160 $12,100 $3,958 32.7%
92134 Imaging of retina Office 2023 53 55 $4,225 $1,635 38.7%
92250 Photography of the retina Office 2023 59 59 $7,475 $1,553 20.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 21 21 $1,425 $907.92 63.7%
92020 Exam of the internal drainage system of eye Office 2023 21 22 $1,100 $418.83 38.1%
92014 Established patient complete exam of visual system Office 2022 739 779 $120,700 $70,267 58.2%
92012 Established patient problem focused exam of visual system Office 2022 163 200 $22,560 $13,019 57.7%
92004 New patient complete exam of visual system Office 2022 73 73 $14,075 $8,068 57.3%
92083 Exam of visual field with extended testing Office 2022 172 182 $18,600 $7,691 41.4%
92133 Imaging of optic nerve Office 2022 152 157 $11,925 $3,692 31.0%
92134 Imaging of retina Office 2022 50 51 $3,875 $1,371 35.4%
92250 Photography of the retina Office 2022 36 36 $4,600 $1,030 22.4%
92020 Exam of the internal drainage system of eye Office 2022 14 14 $700.00 $280.03 40.0%
76514 Ultrasound scan of cornea to determine thickness Office 2022 12 12 $360.00 $111.59 31.0%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 620 646 $98,475 $59,867 60.8%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2021 159 183 $20,130 $12,022 59.7%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2021 101 101 $20,015 $11,530 57.6%
92083 Measurement of field of vision during daylight conditions, extended examination Office 2021 150 154 $15,500 $6,775 43.7%
92133 Diagnostic imaging of optic nerve of eye Office 2021 123 127 $9,525 $3,258 34.2%
92134 Diagnostic imaging of retina Office 2021 43 43 $3,225 $1,359 42.2%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 26 27 $1,755 $1,109 63.2%

About Dr. Michael Piacentini, M.D

Dr. Michael Piacentini, M.D is a Ophthalmology healthcare provider based in Manchester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477547941.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Piacentini, M.D has received a total of $383.66 in payments from pharmaceutical and medical device companies, with $55.24 received in 2024. These payments were reported across 17 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($383.66).

As a Medicare-enrolled provider, Piacentini has provided services to 5,149 Medicare beneficiaries, totaling 5,448 services with total Medicare billing of $388,147. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location Manchester, MA
  • Active Since 09/09/2005
  • Last Updated 05/17/2010
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1477547941

Products in Payments

  • XIIDRA (Drug) $95.28
  • TRAVATAN Z (Drug) $43.42
  • Cequa (Drug) $30.66
  • ILUX (Device) $29.16
  • VUITY (Drug) $24.77
  • MIEBO (Drug) $24.58
  • Rhopressa (Drug) $23.88
  • PAZEO (Drug) $23.30
  • TYRVAYA (Drug) $20.47
  • rocklatan (Drug) $19.41
  • Flarex (Drug) $19.36
  • Avenova (Device) $15.38
  • Bromsite (Drug) $13.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Manchester